Stock ATXI AVENUE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Avenue Therapeutics, Inc.

Equities

ATXI

US05360L4032

Market Closed - Nasdaq
Other stock markets
 21:30:00 05/07/2024 BST 		5-day change 1st Jan Change
3.345 USD -1.91% Intraday chart for Avenue Therapeutics, Inc. -4.43% -72.30%
05-16 Avenue Therapeutics, Inc Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) CI
05-15 Avenue Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AVENUE THERAPEUTICS, INC.
Bio Therapeutic Drugs
-1.91%-4.43%-72.30%-96.16%-99.95% 3.15M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ATXI Stock
  4. Charts Avenue Therapeutics, Inc.
  5. Comparison Chart